NETANYA, Israel, August 4, 2011 /PRNewswire/ --
Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company"), announced today the dismissal of several purported class actions filed against the Company in December 2010, by plaintiffs alleging to be the Company's subscribers, claiming compensation for damages in connection with the network malfunction that occurred on December 1, 2010.In December 2010 nine purported class actions were filed against the company in relation to such network malfunction. Three purported class actions (for the claimed amounts of approximately NIS 200 million, 57 million and NIS 22 million) were dismissed following their respective plaintiff's request. In May 2011, the court approved a procedural agreement among the plaintiffs of the other six lawsuits, according to which all but one of these six purported class actions will be withdrawn at their respective plaintiffs' request, and that the purported class action for the claimed amount of approximately NIS 61 million will remain pending and, to the extent requested by the other plaintiffs until June 2011, be amended to include causes of actions and remedies alleged in any of the other five purported class actions. One purported class action (for the claimed amount of approximately NIS 1.18 billion) was dismissed as part of a procedural agreement. Three purported class actions (for the claimed amounts of approximately NIS 1.32 billion, NIS 1.3 billion and NIS 990 million) were dismissed after having failed to comply with the Courts' orders regarding the procedural agreement. The plaintiffs in the eighth lawsuit (for the claimed amount of NIS 25 million) also requested to withdraw, as part of the procedural agreement. To date, no amendment to the remaining purported class action (according to the procedural agreement) was requested.
For additional details see the Company's annual report on Form 20-F for the year ended December 31, 2010, under "Item 8 - Financial Information - A. Consolidated Statements and Other Financial Information -Legal Proceedings".
NETANYA, Israel, November 2, 2011 /PRNewswire/ --
Cellcom Israel Ltd. (NYSE: CEL) (the "Company") announced that a purported class action lawsuit against the Company was filed in the District Court of Jerusalem, by plaintiffs alleging to be subscribers of the Company, in connection with the allegation that the Company raised tariffs for business customers, unlawfully and in violation of its agreements with them.
The total amount claimed from the Company, if the lawsuit is certified as a class action, is estimated by the plaintiffs to be at least hundreds of millions of NIS.
At this preliminary stage, the Company is unable to assess the lawsuit's chances of success.
NETANYA, Israel, August 23, 2011 /PRNewswire/ --
Cellcom Israel Ltd. (NYSE: CEL) (the "Company") announced that a purported class action lawsuit against the Company and two other cellular operators was filed in the District Court of Central Region, by plaintiffs alleging to be subscribers of the defendants. The plaintiffs allege that the defendants unlawfully and in violation of their licenses charged their subscribers based on units which are different than the units allegedly required by the defendants' licenses, for calls initiated or received by the subscribers while abroad.
The plaintiffs did not state any estimate of the total amount claimed from any of the defendants, if the lawsuit is certified as a class action.
At this preliminary stage, the Company is unable to assess the lawsuit's chances of success.
Recent CEL News
- Celadon Pharmaceuticals PLC Result of AGM • RNS Regulatory News • 06/28/2024 06:00:12 AM
- Celadon Pharmaceuticals PLC Second Admission of Shares • RNS Regulatory News • 06/07/2024 06:00:09 AM
- No Headline Available • Alliance News • 06/03/2024 05:01:12 PM
- Celadon Pharmaceuticals PLC Publication of Annual Report & Notice of AGM • RNS Regulatory News • 06/03/2024 04:45:01 PM
- Celadon ships to US; Oxford BioDynamics-Goodbody pact • Alliance News • 05/23/2024 08:08:53 PM
- Celadon Pharmaceuticals PLC Supply of Products to New US Customer • RNS Regulatory News • 05/23/2024 06:00:13 AM
- Celadon Pharmaceuticals PLC Exercise of Share Options and Total Voting Rights • RNS Regulatory News • 05/15/2024 01:45:01 PM
- Headlam warns of loss; EnSilica predicts revenue rise • Alliance News • 05/14/2024 06:41:32 PM
- Celadon Pharmaceuticals PLC Final Results • RNS Regulatory News • 05/14/2024 06:00:12 AM
- Celadon raises GBP2 million, extends credit facility • Alliance News • 05/10/2024 05:57:23 PM
- Celadon Pharmaceuticals PLC Fundraise, RCF Extension, Termination of CLN & TVR • RNS Regulatory News • 05/10/2024 06:00:08 AM
- Celadon hails early results of chronic pain trial • Alliance News • 03/08/2024 08:04:45 PM
- Celadon Pharmaceuticals PLC Early Economic Analysis of Feasibility Study Data • RNS Non-Regulatory • 03/07/2024 07:00:13 AM
- Celadon announces start of cannabis supply for two UK companies • Alliance News • 12/14/2023 02:18:53 PM
- Celadon Pharmaceuticals PLC Product Supplied to First Two Sales Contracts • UK Regulatory • 12/14/2023 07:00:00 AM
- Celadon Pharma raises GBP2.0 million via placing • Alliance News • 12/12/2023 05:40:04 PM
- Celadon Pharmaceuticals PLC Fundraise, Update on Future CLN Financing & TVR • UK Regulatory • 12/12/2023 02:00:00 PM
- Celadon shares rise on supply contract worth up to GBP26 million • Alliance News • 11/16/2023 11:45:35 AM
- Celadon Pharmaceuticals PLC New European Sales Contract • UK Regulatory • 11/16/2023 07:00:00 AM
- Celadon Pharmaceuticals raises GBP1.0 million through shares • Alliance News • 10/13/2023 02:42:26 PM
- Celadon Pharmaceuticals PLC Fundraise, CLN Issue, Joint Broker Appointed & TVR • UK Regulatory • 10/13/2023 06:00:00 AM
- Celadon Pharmaceuticals interim loss narrows; optimistic for future • Alliance News • 09/28/2023 11:14:47 AM
- Celadon Pharmaceuticals PLC Interim Results • UK Regulatory • 09/28/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 09/18/2023 06:00:00 AM
- Celadon shares rise on second UK contract win for cannabis product • Alliance News • 09/05/2023 09:48:42 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM